Drug discovery for the developing world: Progress at the Novartis Institute for Tropical Diseases

Catherine L. Jones; Bryan K.S. Yeung; Ujjini Manjunatha; Pei Yong Shi; Christophe Bodenreider; Thierry T. Diagana

doi:10.1038/nrd4001-c1

Drug discovery for the developing world: Progress at the Novartis Institute for Tropical Diseases

Catherine L. Jones, Bryan K.S. Yeung, Ujjini Manjunatha, Pei Yong Shi, Christophe Bodenreider, Thierry T. Diagana

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	442-444
Number of pages	3
Journal	Nature Reviews Drug Discovery
Volume	14
Issue number	6
DOIs	https://doi.org/10.1038/nrd4001-c1
State	Published - Jun 3 2015
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd4001-c1

Cite this

@article{7a6dcee42dfe490e9a5af7d9a69403d3,

title = "Drug discovery for the developing world: Progress at the Novartis Institute for Tropical Diseases",

author = "Jones, {Catherine L.} and Yeung, {Bryan K.S.} and Ujjini Manjunatha and Shi, {Pei Yong} and Christophe Bodenreider and Diagana, {Thierry T.}",

note = "Funding Information: With support from the EDB, the Wellcome Trust and the Medicines for Malaria Venture, the NITD and three collaborators (the Genomics Institute of the Novartis Research Foundation (GNF), the Biomedical Primate Research Centre and the Swiss Tropical Public Health Institute) have the ambitious goal of a single-dose cure for Plasmodium falciparum malaria. So far, several phenotypic screens have yielded over 500 scaffolds with antimalarial properties (ChEMBL-NTD).",

year = "2015",

month = jun,

day = "3",

doi = "10.1038/nrd4001-c1",

language = "English (US)",

volume = "14",

pages = "442--444",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Drug discovery for the developing world

T2 - Progress at the Novartis Institute for Tropical Diseases

AU - Jones, Catherine L.

AU - Yeung, Bryan K.S.

AU - Manjunatha, Ujjini

AU - Shi, Pei Yong

AU - Bodenreider, Christophe

AU - Diagana, Thierry T.

N1 - Funding Information: With support from the EDB, the Wellcome Trust and the Medicines for Malaria Venture, the NITD and three collaborators (the Genomics Institute of the Novartis Research Foundation (GNF), the Biomedical Primate Research Centre and the Swiss Tropical Public Health Institute) have the ambitious goal of a single-dose cure for Plasmodium falciparum malaria. So far, several phenotypic screens have yielded over 500 scaffolds with antimalarial properties (ChEMBL-NTD).

PY - 2015/6/3

Y1 - 2015/6/3

UR - http://www.scopus.com/inward/record.url?scp=84930333856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930333856&partnerID=8YFLogxK

U2 - 10.1038/nrd4001-c1

DO - 10.1038/nrd4001-c1

M3 - Letter

C2 - 26027536

AN - SCOPUS:84930333856

SN - 1474-1776

VL - 14

SP - 442

EP - 444

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 6

ER -

Drug discovery for the developing world: Progress at the Novartis Institute for Tropical Diseases

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this